Alternate biomarkers in predicting CD4+ T cell count in HIV patients
Biomarkers in predicting CD4+ T cell count for initiation of antiretroviral therapy in HIV patients in north western Nigeria
978-620-2-07086-7
6202070862
72
2018-02-27
35,90 €
eng
https://images.our-assets.com/cover/230x230/9786202070867.jpg
https://images.our-assets.com/fullcover/230x230/9786202070867.jpg
https://images.our-assets.com/cover/2000x/9786202070867.jpg
https://images.our-assets.com/fullcover/2000x/9786202070867.jpg
In many resource-poor countries, most facilities do not have cyflow counter for the performance of CD4+ count analysis required for the initiation of antiretroviral therapy. CD4+ T cell count and viral load monitoring are expensive and unavailable to most human immunodeficiency virus (HIV) infected people in Africa. There is a need to have another marker of HIV infection that is less resource demanding. Studies in human immunodeficiency virus infected adults have demonstrated association of total lymphocyte count (TLC) <1200 cell/µl and subsequent disease progression or mortality. This study was carried out to determine the relationship of CD4+ T lymphocyte counts with total lymphocyte count (TLC) and immunoglobulin G (IgG) in HIV- positive on highly active antiretroviral therapy (HAART) naive patients attending Specialist Hospital Sokoto northern region, Nigeria. The study population comprised of 100 adult HIV-positive HAART naive patients aged 19-65 years. The CD4+ T cell counts and these alternate biomarkers of study participants were measured. Spearman's rank order correlation was used for statistical analysis.
https://morebooks.de/books/it/published_by/lap-lambert-academic-publishing/47/products
Medicina
https://morebooks.de/store/it/book/alternate-biomarkers-in-predicting-cd4+-t-cell-count-in-hiv-patients/isbn/978-620-2-07086-7